The Heparin Market exhibits a steady growth trajectory, with an estimated value of USD 7.71 billion in 2023 and a projected increase to USD 9.61 billion by 2031. This growth is anticipated to be driven by a compound annual growth rate (CAGR) of approximately 2.8% over the forecast period spanning from 2024 to 2031. Several factors contribute to this expansion, including the rising prevalence of cardiovascular diseases and venous thromboembolism, which are key indications for heparin use. Additionally, advancements in pharmaceutical manufacturing techniques and increased adoption of heparin-based products for various medical applications further fuel market growth. As healthcare systems worldwide prioritize anticoagulant therapies for managing thrombotic disorders, the Heparin Market is positioned for sustained growth, catering to the evolving needs of patients and healthcare providers alike.